Finished
Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
NCT00736645 · Roswell Park Cancer Institute · Updated 2 Oct 2023
- What is being tested
- selenomethionine; finasteride; placebo
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years and older. About 55 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started Aug 2008, ends Dec 2012. Registered 18 Aug 2008.
- Results
- Posted on the registry on 28 Nov 2017.
In the researchers' words
RATIONALE: Selenomethionine may slow the growth of prostate cancer. Testosterone can cause the growth of prostate cancer cells. Finasteride may fight prostate cancer by lowering the amount of testosterone the body makes. Giving selenomethionine together with finasteride before surgery or radiation therapy may be an effective treatment for prostate cancer. PURPOSE: This randomized phase II trial is studying how well selenomethionine and finasteride work when given before surgery or radiation therapy in treating patients with stage I or stage II prostate cancer.
Sites
- Roswell Park Cancer InstituteBuffalo, New York, United States